Bain Capital Public Equity Management Ii, LLC Bristol Myers Squibb CO Transaction History

Bain Capital Public Equity Management Ii, LLC

$2.33 Billion
Q1 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2021 Aug 16, 2021	SELL	$61.91 - $67.42 $32.9 Million - $35.8 Million	-531,424 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$59.34 - $66.74 $31.5 Million - $35.5 Million	531,424 New	531,424 $33.5 Million

Others Institutions Holding BMY

# of Institutions

2,553

Shares Held

1.49B

Call Options Held

25.9M

Put Options Held

20M

Vanguard Group Inc Valley Forge, PA

186M
Shares

$7.53 Billion
0.2% of portfolio
Black Rock Inc. New York, NY

163M
Shares

$6.58 Billion
0.21% of portfolio
State Street Corp Boston, MA

91.6M
Shares

$3.7 Billion
0.23% of portfolio
Jpmorgan Chase & CO New York, NY

88.8M
Shares

$3.59 Billion
0.44% of portfolio
Capital International Investors Los Angeles, CA

70.2M
Shares

$2.84 Billion
0.79% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $86B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bain Capital Public Equity Management Ii, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bain Capital Public Equity Management Ii, LLC with notifications on news.

Account